Amrit Ray
Direktor/Vorstandsmitglied bei ULTRAGENYX PHARMACEUTICAL INC.
Vermögen: 538 478 $ am 30.04.2024
Aktive Positionen von Amrit Ray
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Direktor/Vorstandsmitglied | 19.04.2022 | - |
Independent Dir/Board Member | 19.04.2022 | - | |
FORTREA HOLDINGS INC. | Direktor/Vorstandsmitglied | 29.06.2023 | - |
Independent Dir/Board Member | 29.06.2023 | - | |
CorEvitas LLC
CorEvitas LLC BiotechnologyHealth Technology CorEvitas LLC engages in the provision of medical research services. It offers real-world evidence solutions; safety; patient engagement; precision medicine biorepository. The company was founded by Joel Kremer in 2001 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | 03.08.2021 | - |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Amrit Ray
Ehemalige bekannte Positionen von Amrit Ray
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 01.03.2022 | 01.12.2022 |
PFIZER, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | 01.01.2021 |
JOHNSON & JOHNSON | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Amrit Ray
The University of Edinburgh | Doctorate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 9 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 5 |
Commercial Services | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
FORTREA HOLDINGS INC. | Commercial Services |
JOHNSON & JOHNSON | Health Technology |
PFIZER, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
CorEvitas LLC
CorEvitas LLC BiotechnologyHealth Technology CorEvitas LLC engages in the provision of medical research services. It offers real-world evidence solutions; safety; patient engagement; precision medicine biorepository. The company was founded by Joel Kremer in 2001 and is headquartered in Waltham, MA. | Health Technology |
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Commercial Services |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Commercial Services |